Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Lotion

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    33 result(s) found for: Lotion. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2009-016629-33 Sponsor Protocol Number: H521000-0914 Start Date*: 2009-12-22
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A 12 day placebo- and reference-controlled, double-blind, single center, randomized, phase II clinical study with an intraindividual comparison, investigating the anti-psoriatic efficacy and the to...
    Medical condition: Psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-002209-23 Sponsor Protocol Number: V01-122A-401 Start Date*: 2020-07-22
    Sponsor Name:Bausch Health Americas, Inc.(affiliate of Bausch Health US ,formerly known as Dow Pharmaceutical Sciences)
    Full Title: A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion i...
    Medical condition: Moderate to Severe Plaque Psoriasis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2019-002406-43 Sponsor Protocol Number: V01-118A-401 Start Date*: 2020-07-31
    Sponsor Name:Bausch Health Americas, Inc.(affiliate of Bausch Health US , LLC, formerly known as Dow Pharmaceutical Sciences)
    Full Title: A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion i...
    Medical condition: Moderate to severe Plaque Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10071117 Plaque psoriasis LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2004-005085-21 Sponsor Protocol Number: KCSA-03 Start Date*: 2005-12-13
    Sponsor Name:Dermal Laboratories Limited
    Full Title: Scalp lotion for the treatment of pityriasis capitis (severe dandruff) and seborrhoeic dermatitis.
    Medical condition: Seborrhoeic dermatitis and pityriasis capitis of the scalp.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-001519-39 Sponsor Protocol Number: 2008-02-12-1 Start Date*: Information not available in EudraCT
    Sponsor Name:Biologiske Stasjon Drøbak
    Full Title: Efficiency of a jellyfish sting inhibitor sun lotion and protocols for jellyfish sting pain relief
    Medical condition: The degree of pain reduction in test subjects using a specific jellyfish (cnidaria) sting inhibitor and repellent lotion, compared to control subjects being protected by a normal water repellent su...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-001844-34 Sponsor Protocol Number: V03777 LE 301A Start Date*: 2007-11-26
    Sponsor Name:Pierre Fabre Dermo-Cosmétique
    Full Title: Non inferiority study of a malathion 0.5% lotion versus reference therapy in the treatment of head lice: multicentre, randomised, investigator masked, parallel group.
    Medical condition: the patient who will be included in this clinical trial present a confirmed active head lice infestation.
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) BE (Completed) IT (Completed) EE (Completed)
    Trial results: View results
    EudraCT Number: 2010-019804-21 Sponsor Protocol Number: CTWE01 Start Date*: 2010-05-18
    Sponsor Name:Wepa Apothekenbedarf GmbH & Co KG
    Full Title: A randomised, controlled, assessor-blind, clinical investigation of the activity of mosquito® LäuseShampoo compared with Infectopedicul® permethrin 0.5% lotion in the treatment of head lice
    Medical condition: Infestation by head lice (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019199 Head pediculosis LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004136-73 Sponsor Protocol Number: CTMK05 Start Date*: 2006-09-14
    Sponsor Name:Thornton & Ross Limited
    Full Title: A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice
    Medical condition: Head louse infestation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10034214 Pediculus capitis (head louse) LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005787-13 Sponsor Protocol Number: CTMK08 Start Date*: 2008-10-27
    Sponsor Name:Thornton & Ross Ltd
    Full Title: A proof of concept clinical investigation to evaluate the activity of Hedrin 4% lotion in the treatment of head lice using a 1 hour application time
    Medical condition: Head louse infestation (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10034214 Pediculus capitis (head louse) LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-006190-87 Sponsor Protocol Number: CTOM01 Start Date*: 2008-03-04
    Sponsor Name:Omega Pharma N.V.
    Full Title: A randomised, controlled, assessor-blind, clinical trial to investigate superiority of Lyclear spray away (ParaNix spray) compared with Infectopedicul permethrin 0.5% lotion in the treatment of hea...
    Medical condition: Infestation by head lice (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019199 Head pediculosis LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016261-28 Sponsor Protocol Number: H 521 000 - 0915 Start Date*: 2010-01-26
    Sponsor Name:Almirall Hermal GmbH
    Full Title: Randomized, observer-blind, multi-center, reference-controlled phase IIb study to evaluate the efficacy of topically applied LAS41002 lotion in the treatment of scalp psoriasis
    Medical condition: Psoriasis vulgaris on the scalp
    Disease: Version SOC Term Classification Code Term Level
    12.0 10037157 Psoriasis of scalp LLT
    12.0 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-002258-10 Sponsor Protocol Number: IBRB-02 Start Date*: 2016-10-19
    Sponsor Name:Dermal Laboratories Ltd
    Full Title: SINCERE: A single-centre, assessor blind, randomised pilot study to evaluate the safety, tolerability and acceptability of RB Lotion compared to standard-of-care for Radiation Induced Skin Reaction...
    Medical condition: Radiation Induced Skin Reactions (RISR)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004863 10061103 Dermatitis radiation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-004765-90 Sponsor Protocol Number: DFD03-CD-004 Start Date*: 2016-07-13
    Sponsor Name:Dr. Reddy’s Laboratories, Ltd
    Full Title: A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
    Medical condition: Acne vulgaris
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-001574-42 Sponsor Protocol Number: FPC117291 Start Date*: 2017-09-21
    Sponsor Name:GlaxoSmithKline Research & Development Ltd
    Full Title: A randomized, open-label, comparative study to evaluate an intermittent dosing regimen of fluticasone propionate 0·05% cream (twice per week) in reducing the risk of relapse when added to regular d...
    Medical condition: stabilized atopic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000018018 10003639 Atopic dermatitis LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2018-004338-13 Sponsor Protocol Number: TOPIC Start Date*: 2019-06-11
    Sponsor Name:Department of Dermatology, Erasmus University Medical Center
    Full Title: Short term clinical efficacy of topical treatment with clindamycin-benzoyl peroxide gel compared with clindamycin lotion in mild to moderate Hidradenitis Suppurativa
    Medical condition: Hidradenitis Suppurativa
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10020041 Hidradenitis suppurativa LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016591-68 Sponsor Protocol Number: 09.15 Start Date*: 2009-12-22
    Sponsor Name:Odense University Hospital
    Full Title: Placebo-controlled trial investigating the effect of Vitamin K3-lotion for the treatment of cetuximab induced folliculitis
    Medical condition: Cancer patients experiencing folliculitis due to treatment with cetuximab
    Disease: Version SOC Term Classification Code Term Level
    12.0 10061451 Colorectal cancer LLT
    12.0 10067821 Head and neck cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-016571-30 Sponsor Protocol Number: DERL-02 Start Date*: 2010-02-01
    Sponsor Name:Dermal Laboratories Ltd
    Full Title: A study to determine the effects on stratum corneum of a clinical hand cleansing protocol comparing two antiseptic hand washes, using non-invasive instrumental methods in human volunteers.
    Medical condition: No medical condition is to be investigated, as such. We are looking to avoid occupational hand dermatitis in healthcare professionals, simulated using a repeat hand wash cleansing protocol in heal...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-005512-24 Sponsor Protocol Number: CT EP 01 Start Date*: 2006-04-27
    Sponsor Name:EctoPharma Limited
    Full Title: A phase IIa clinical trial to demonstrate the proof of concept of an experimental pediculicide lotion for the treatment of head lice
    Medical condition: Head louse infection
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002128-14 Sponsor Protocol Number: Local/2007/MD-01 Start Date*: 2009-02-11
    Sponsor Name:CHU de Nîmes
    Full Title: Anesthésie topique versus anesthésie épisclérale pour chirurgie de la cataracte
    Medical condition: Cataracte bilatérale
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-000333-22 Sponsor Protocol Number: DERL-01 Start Date*: 2008-04-30
    Sponsor Name:Dermal Laboratories Ltd
    Full Title: A study to compare the effects on stratum corneum of two medical hand wash formulations, using non-invasive instrumental methods in human volunteers.
    Medical condition: The study is a healthy volunteer study.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 24 15:59:42 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA